JNJ

J&J's Experimental Ebola Vaccine to be Deployed in the Congo to Help Stem Outbreak
J&J's Experimental Ebola Vaccine to be Deployed in the Congo to Help Stem Outbreak
BioSpace
JNJ
Congo
vaccines
WHO
ebola virus
Flag link:
Pfizer, GSK, J&J and more strike $248M deal to exit long-running Medicaid fraud suit
Pfizer, GSK, J&J and more strike $248M deal to exit long-running Medicaid fraud suit
Fierce Pharma
Medicaid
settlement
GSK
JNJ
Pfizer
Flag link:
Justice Department issues grand jury subpoenas in J&J opioid probe: filing
Justice Department issues grand jury subpoenas in J&J opioid probe: filing
Yahoo/Reuters
JNJ
opioids
opioid crisis
Flag link:
J&J’s Auris Has Solid Data to Support Monarch
J&J’s Auris Has Solid Data to Support Monarch
Medical Devices and Diagnostics Industry
JNJ
Auris Health
Monarch robots
devices
M&
Flag link:
J&J slashes third-quarter profit by $3 bln over proposed opioid deal
J&J slashes third-quarter profit by $3 bln over proposed opioid deal
Yahoo/Reuters
JNJ
earnings
opioids
settlements
opioid crisis
Flag link:
Several states wary of $48 billion opioid settlement proposal
Several states wary of $48 billion opioid settlement proposal
Yahoo/Reuters
opioids
opioid crisis
Amerisource Bergen
Cardinal Health
JNJ
Teva Pharmaceutical
McKesson
Ohio
New Hampshire
West Virginia
Flag link:
Provention Bio's J&J-licensed Crohn's drug stumbles in mid-stage study
Provention Bio's J&J-licensed Crohn's drug stumbles in mid-stage study
Endpoints
Provention Bio
JNJ
Crohn's Disease
clinical trials
PRV-6527
Flag link:
Report: Johnson & Johnson CEO ‘Believed’ Baby Powder Was Asbestos-Free 13 Days Before FDA Found Trace Levels
Report: Johnson & Johnson CEO ‘Believed’ Baby Powder Was Asbestos-Free 13 Days Before FDA Found Trace Levels
Forbes
JNJ
Alex Gorsky
FDA
Flag link:
Janssen’s Stelara Wins FDA Approval for Ulcerative Colitis
Janssen’s Stelara Wins FDA Approval for Ulcerative Colitis
BioSpace
JNJ
Janssen
Stelara
FDA
ulcerative colitis
Flag link:
J&J’s Tremfya Shows Extended Success in Treating Plaque Psoriasis
J&J’s Tremfya Shows Extended Success in Treating Plaque Psoriasis
BioSpace
JNJ
Janssen
Tremfya
clinical trials
psoriasis
Flag link:
JNJ sheds light on why its settling some opioid cases instead of fighting in court
JNJ sheds light on why its settling some opioid cases instead of fighting in court
Yahoo
JNJ
opioids
opioid crisis
lawsuits
Flag link:
UCB's bispecific beats J&J's Stelara in psoriasis phase 3
UCB's bispecific beats J&J's Stelara in psoriasis phase 3
Fierce Biotech
UCB Pharma
bispecific antibodies
bimekizumab
JNJ
Stelara
psoriasis
Flag link:
AbbVie's blockbuster hopeful Rinvoq, J&J's Spravato eye EU rollouts, thanks to new backing
AbbVie's blockbuster hopeful Rinvoq, J&J's Spravato eye EU rollouts, thanks to new backing
Fierce Pharma
AbbVie
Rinvoq
Europe
JNJ
Spravato
Flag link:
J&J's Xarelto, Amarin's Vascepa are cost-effective, not budget friendly — ICER
J&J's Xarelto, Amarin's Vascepa are cost-effective, not budget friendly — ICER
Endpoints
ICER
drug pricing
JNJ
Xarelto
Amarin
Vascepa
Flag link:
J&J Recalls Lot of Baby Powder After Asbestos Trace Found
J&J Recalls Lot of Baby Powder After Asbestos Trace Found
Yahoo/Bloomberg
JNJ
FDA
product recalls
Flag link:
Is the US opioid litigation nearing an end game?
Is the US opioid litigation nearing an end game?
Pharmaforum
lawsuits
opioids
opioid crisis
JNJ
Teva Pharmaceutical
AmerisourceBergen
Cardinal Health
McKesson
Flag link:
Lawsuit-ridden J&J tumbles in annual listing of best global brands
Lawsuit-ridden J&J tumbles in annual listing of best global brands
Fierce Pharma
JNJ
reputation
lawsuits
branding
Flag link:
J&J wins reversal of $110M talc verdict, its 4th appeals win in Missouri
J&J wins reversal of $110M talc verdict, its 4th appeals win in Missouri
Fierce Pharma
JNJ
Missouri
Flag link:
Teva, J&J make multibillion-dollar settlement offers as opioid trial gets going
Teva, J&J make multibillion-dollar settlement offers as opioid trial gets going
Fierce Pharma
Teva Pharmaceutical
JNJ
opioids
opioid crisis
Flag link:
Prescription drugs boost drives J&J forecasts higher, shares rise
Prescription drugs boost drives J&J forecasts higher, shares rise
Yahoo/Reuters
JNJ
earnings
Stelara
Imbruvica
Flag link:

Pages